Neuroleptic responsivity of negative and positive symptoms in schizophrenia

Alan Breier, O. M. Wolkowitz, A. R. Doran, A. Roy, J. Boronow, D. W. Hommer, D. Pickar

Research output: Contribution to journalArticle

98 Citations (Scopus)

Abstract

The authors prospectively examined the effects of double-blind, placebo-controlled neuroleptic withdrawal and administration on ratings of negative and positive symptoms in 19 young patients with chronic schizophrenia. Negative symptoms were significantly reduced by neuroleptic treatment, and negative and positive symptoms demonstrated similar patterns of reduction and exacerbation during neuroleptic treatment and withdrawal, respectively. The changes in negative and positive symptoms induced by neuroleptic treatment and withdrawal were not significantly correlated, however. The negative and positive symptom profiles of individual patients were significantly altered by neuroleptic treatment, indicating limitations to the cross-sectional classification of patients on the basis of predominance of one or the other symptom group. The authors discuss implications for the neurobiological underpinnings of negative and positive symptoms.

Original languageEnglish (US)
Pages (from-to)1549-1555
Number of pages7
JournalAmerican Journal of Psychiatry
Volume144
Issue number12
StatePublished - 1987
Externally publishedYes

Fingerprint

Antipsychotic Agents
Schizophrenia
Therapeutics
Placebos

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Breier, A., Wolkowitz, O. M., Doran, A. R., Roy, A., Boronow, J., Hommer, D. W., & Pickar, D. (1987). Neuroleptic responsivity of negative and positive symptoms in schizophrenia. American Journal of Psychiatry, 144(12), 1549-1555.

Neuroleptic responsivity of negative and positive symptoms in schizophrenia. / Breier, Alan; Wolkowitz, O. M.; Doran, A. R.; Roy, A.; Boronow, J.; Hommer, D. W.; Pickar, D.

In: American Journal of Psychiatry, Vol. 144, No. 12, 1987, p. 1549-1555.

Research output: Contribution to journalArticle

Breier, A, Wolkowitz, OM, Doran, AR, Roy, A, Boronow, J, Hommer, DW & Pickar, D 1987, 'Neuroleptic responsivity of negative and positive symptoms in schizophrenia', American Journal of Psychiatry, vol. 144, no. 12, pp. 1549-1555.
Breier A, Wolkowitz OM, Doran AR, Roy A, Boronow J, Hommer DW et al. Neuroleptic responsivity of negative and positive symptoms in schizophrenia. American Journal of Psychiatry. 1987;144(12):1549-1555.
Breier, Alan ; Wolkowitz, O. M. ; Doran, A. R. ; Roy, A. ; Boronow, J. ; Hommer, D. W. ; Pickar, D. / Neuroleptic responsivity of negative and positive symptoms in schizophrenia. In: American Journal of Psychiatry. 1987 ; Vol. 144, No. 12. pp. 1549-1555.
@article{7cb6fd14ca334ca2b4cb3efa7d6348f6,
title = "Neuroleptic responsivity of negative and positive symptoms in schizophrenia",
abstract = "The authors prospectively examined the effects of double-blind, placebo-controlled neuroleptic withdrawal and administration on ratings of negative and positive symptoms in 19 young patients with chronic schizophrenia. Negative symptoms were significantly reduced by neuroleptic treatment, and negative and positive symptoms demonstrated similar patterns of reduction and exacerbation during neuroleptic treatment and withdrawal, respectively. The changes in negative and positive symptoms induced by neuroleptic treatment and withdrawal were not significantly correlated, however. The negative and positive symptom profiles of individual patients were significantly altered by neuroleptic treatment, indicating limitations to the cross-sectional classification of patients on the basis of predominance of one or the other symptom group. The authors discuss implications for the neurobiological underpinnings of negative and positive symptoms.",
author = "Alan Breier and Wolkowitz, {O. M.} and Doran, {A. R.} and A. Roy and J. Boronow and Hommer, {D. W.} and D. Pickar",
year = "1987",
language = "English (US)",
volume = "144",
pages = "1549--1555",
journal = "American Journal of Psychiatry",
issn = "0002-953X",
publisher = "American Psychiatric Association",
number = "12",

}

TY - JOUR

T1 - Neuroleptic responsivity of negative and positive symptoms in schizophrenia

AU - Breier, Alan

AU - Wolkowitz, O. M.

AU - Doran, A. R.

AU - Roy, A.

AU - Boronow, J.

AU - Hommer, D. W.

AU - Pickar, D.

PY - 1987

Y1 - 1987

N2 - The authors prospectively examined the effects of double-blind, placebo-controlled neuroleptic withdrawal and administration on ratings of negative and positive symptoms in 19 young patients with chronic schizophrenia. Negative symptoms were significantly reduced by neuroleptic treatment, and negative and positive symptoms demonstrated similar patterns of reduction and exacerbation during neuroleptic treatment and withdrawal, respectively. The changes in negative and positive symptoms induced by neuroleptic treatment and withdrawal were not significantly correlated, however. The negative and positive symptom profiles of individual patients were significantly altered by neuroleptic treatment, indicating limitations to the cross-sectional classification of patients on the basis of predominance of one or the other symptom group. The authors discuss implications for the neurobiological underpinnings of negative and positive symptoms.

AB - The authors prospectively examined the effects of double-blind, placebo-controlled neuroleptic withdrawal and administration on ratings of negative and positive symptoms in 19 young patients with chronic schizophrenia. Negative symptoms were significantly reduced by neuroleptic treatment, and negative and positive symptoms demonstrated similar patterns of reduction and exacerbation during neuroleptic treatment and withdrawal, respectively. The changes in negative and positive symptoms induced by neuroleptic treatment and withdrawal were not significantly correlated, however. The negative and positive symptom profiles of individual patients were significantly altered by neuroleptic treatment, indicating limitations to the cross-sectional classification of patients on the basis of predominance of one or the other symptom group. The authors discuss implications for the neurobiological underpinnings of negative and positive symptoms.

UR - http://www.scopus.com/inward/record.url?scp=0023483369&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023483369&partnerID=8YFLogxK

M3 - Article

C2 - 3688278

AN - SCOPUS:0023483369

VL - 144

SP - 1549

EP - 1555

JO - American Journal of Psychiatry

JF - American Journal of Psychiatry

SN - 0002-953X

IS - 12

ER -